Total Payments
$6,338
2024 Payments
$1,128
Companies
18
Transactions
257
Medicare Patients
1,137
Medicare Billing
$124,832
Payment Breakdown by Category
Food & Beverage$6,317 (99.7%)
Education$20.84 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,317 | 254 | 99.7% |
| Education | $20.84 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,360 | 90 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,456 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $981.24 | 36 | $0 (2024) |
| PBG PUERTO RICO LLC | $281.18 | 13 | $0 (2024) |
| Mylan Specialty L.P. | $192.66 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $186.79 | 6 | $0 (2024) |
| Insmed, Inc. | $162.31 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $112.40 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $110.52 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $97.09 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,128 | 45 | AstraZeneca Pharmaceuticals LP ($323.99) |
| 2023 | $815.20 | 31 | GlaxoSmithKline, LLC. ($401.59) |
| 2022 | $838.77 | 32 | GlaxoSmithKline, LLC. ($365.66) |
| 2021 | $745.86 | 37 | GlaxoSmithKline, LLC. ($309.27) |
| 2020 | $697.71 | 32 | GlaxoSmithKline, LLC. ($406.29) |
| 2019 | $900.64 | 31 | GlaxoSmithKline, LLC. ($382.98) |
| 2018 | $702.24 | 28 | GlaxoSmithKline, LLC. ($242.61) |
| 2017 | $509.07 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($200.55) |
All Payment Transactions
257 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/24/2024 | PBG PUERTO RICO LLC | ELIQUIS (Drug), PAXLOVID, ZAVZPRET | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: VACCINE | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Immunology | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $100.49 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/09/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $51.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Respiratory | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 249 | 450 | $33,539 | $24,410 |
| 2022 | 8 | 269 | 481 | $35,546 | $26,003 |
| 2021 | 8 | 286 | 607 | $46,998 | $34,978 |
| 2020 | 8 | 333 | 722 | $54,250 | $39,441 |
Total Patients
1,137
Total Services
2,260
Medicare Billing
$124,832
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 213 | $19,345 | $13,898 | 71.8% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 73 | 128 | $4,945 | $3,482 | 70.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 38 | $3,013 | $2,362 | 78.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $3,183 | $2,362 | 74.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 13 | $1,181 | $854.52 | 72.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 16 | 16 | $919.33 | $703.57 | 76.5% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 11 | 11 | $484.55 | $379.94 | 78.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 12 | 12 | $467.64 | $366.72 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 98 | 205 | $18,935 | $13,289 | 70.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 82 | $5,855 | $4,618 | 78.9% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 73 | 126 | $4,954 | $3,795 | 76.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $2,380 | $1,663 | 69.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 19 | $1,725 | $1,296 | 75.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 12 | 12 | $723.36 | $571.92 | 79.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 11 | 11 | $494.01 | $390.91 | 79.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 12 | 12 | $480.48 | $379.88 | 79.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 102 | 244 | $22,636 | $16,052 | 70.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 160 | $11,518 | $9,214 | 80.0% |
| 94375 | Respiratory diagnostic testing (flow volume loop) | Office | 2021 | 71 | 109 | $4,321 | $3,425 | 79.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 34 | 46 | $4,283 | $3,203 | 74.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $2,556 | $1,737 | 68.0% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 11 | 11 | $668.58 | $534.82 | 80.0% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 11 | 11 | $521.51 | $417.23 | 80.0% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 11 | 11 | $494.23 | $395.34 | 80.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 54 | 275 | $20,269 | $15,764 | 77.8% |
About Dr. Pedro Monroig Quiles, M.D
Dr. Pedro Monroig Quiles, M.D is a Pulmonary Disease healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639152499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pedro Monroig Quiles, M.D has received a total of $6,338 in payments from pharmaceutical and medical device companies, with $1,128 received in 2024. These payments were reported across 257 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($6,317).
As a Medicare-enrolled provider, Monroig Quiles has provided services to 1,137 Medicare beneficiaries, totaling 2,260 services with total Medicare billing of $124,832. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location San Juan, PR
- Active Since 11/25/2005
- Last Updated 10/10/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639152499
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,205
- FASENRA (Biological) $513.07
- NUCALA (Biological) $377.43
- STIOLTO RESPIMAT (Drug) $323.90
- TEZSPIRE (Biological) $298.78
- ELIQUIS (Drug) $287.55
- ANORO ELLIPTA (Drug) $234.98
- ANORO (Drug) $219.43
- FASENRA (Drug) $213.36
- SPIRIVA RESPIMAT (Drug) $208.46
- XARELTO (Drug) $186.79
- CHANTIX (Drug) $171.02
- Arikayce (Drug) $162.31
- SYMBICORT (Drug) $151.87
- BEVESPI AEROSPHERE (Drug) $136.54
- Yupelri (Drug) $132.40
- STIOLTO (Drug) $120.27
- GLASSIA (Biological) $112.40
- YUPELRI (Drug) $107.11
- JARDIANCE (Drug) $100.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in San Juan
Dr. Rafael Franjul Juliao, M.d, M.D
Pulmonary Disease — Payments: $27,437
Pulmonary Disease $27,437
Dr. Daphne Delgado, M.d, M.D
Pulmonary Disease — Payments: $11,197
Pulmonary Disease $11,197
Dr. Edgardo Cartagena Ayala, M.d, M.D
Pulmonary Disease — Payments: $7,958
Pulmonary Disease $7,958
Maria Betancourt Quiles, M.d, M.D
Pulmonary Disease — Payments: $7,543
Pulmonary Disease $7,543
Edgar Rodriguez Gonzalez, M.d, M.D
Pulmonary Disease — Payments: $5,923
Pulmonary Disease $5,923
Ramon Flores, M.d, M.D
Pulmonary Disease — Payments: $5,070
Pulmonary Disease $5,070